270 related articles for article (PubMed ID: 28101527)
21. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
[TBL] [Abstract][Full Text] [Related]
22. A postnatal peak in microglial development in the mouse hippocampus is correlated with heightened sensitivity to seizure triggers.
Kim I; Mlsna LM; Yoon S; Le B; Yu S; Xu D; Koh S
Brain Behav; 2015 Dec; 5(12):e00403. PubMed ID: 26807334
[TBL] [Abstract][Full Text] [Related]
23. Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells.
Pandur E; Tamási K; Pap R; Varga E; Miseta A; Sipos K
Cell Mol Neurobiol; 2019 Oct; 39(7):985-1001. PubMed ID: 31172340
[TBL] [Abstract][Full Text] [Related]
24. Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death.
Lauro C; Cipriani R; Catalano M; Trettel F; Chece G; Brusadin V; Antonilli L; van Rooijen N; Eusebi F; Fredholm BB; Limatola C
Neuropsychopharmacology; 2010 Jun; 35(7):1550-9. PubMed ID: 20200508
[TBL] [Abstract][Full Text] [Related]
25. Excitatory amino acid transporter 2 downregulation correlates with thalamic neuronal death following kainic acid-induced status epilepticus in rat.
Sakurai M; Kurokawa H; Shimada A; Nakamura K; Miyata H; Morita T
Neuropathology; 2015 Feb; 35(1):1-9. PubMed ID: 25059512
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
Seo Y; Kim HS; Kang I; Choi SW; Shin TH; Shin JH; Lee BC; Lee JY; Kim JJ; Kook MG; Kang KS
Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148
[TBL] [Abstract][Full Text] [Related]
27. Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.
Roche SL; Wyse-Jackson AC; Gómez-Vicente V; Lax P; Ruiz-Lopez AM; Byrne AM; Cuenca N; Cotter TG
PLoS One; 2016; 11(11):e0165197. PubMed ID: 27814376
[TBL] [Abstract][Full Text] [Related]
28. IP3-Mediated Calcium Signaling Is Involved in the Mechanism of Fractalkine-Induced Hyperalgesia Response.
Wang A; Yang T; Zhang L; Jia L; Wu Q; Yao S; Xu J; Yang H
Med Sci Monit; 2018 Dec; 24():8804-8811. PubMed ID: 30517088
[TBL] [Abstract][Full Text] [Related]
29. Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina.
Roche SL; Wyse-Jackson AC; Ruiz-Lopez AM; Byrne AM; Cotter TG
Sci Rep; 2017 Feb; 7():43067. PubMed ID: 28216676
[TBL] [Abstract][Full Text] [Related]
30. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.
Harrison JK; Jiang Y; Chen S; Xia Y; Maciejewski D; McNamara RK; Streit WJ; Salafranca MN; Adhikari S; Thompson DA; Botti P; Bacon KB; Feng L
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10896-901. PubMed ID: 9724801
[TBL] [Abstract][Full Text] [Related]
31. PSD-93 mediates the crosstalk between neuron and microglia and facilitates acute ischemic stroke injury by binding to CX3CL1.
Zhang Q; He L; Chen M; Yang H; Cao X; Liu X; Hao Q; Chen Z; Liu T; Wei XE; Rong L
J Neurochem; 2021 Jun; 157(6):2145-2157. PubMed ID: 33599284
[TBL] [Abstract][Full Text] [Related]
32. Modulation of microglial process convergence toward neuronal dendrites by extracellular calcium.
Eyo UB; Gu N; De S; Dong H; Richardson JR; Wu LJ
J Neurosci; 2015 Feb; 35(6):2417-22. PubMed ID: 25673836
[TBL] [Abstract][Full Text] [Related]
33. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.
Zhuang ZY; Kawasaki Y; Tan PH; Wen YR; Huang J; Ji RR
Brain Behav Immun; 2007 Jul; 21(5):642-51. PubMed ID: 17174525
[TBL] [Abstract][Full Text] [Related]
34. New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.
Shan S; Hong-Min T; Yi F; Jun-Peng G; Yue F; Yan-Hong T; Yun-Ke Y; Wen-Wei L; Xiang-Yu W; Jun M; Guo-Hua W; Ya-Ling H; Hua-Wei L; Ding-Fang C
Neurobiol Aging; 2011 Mar; 32(3):443-58. PubMed ID: 19368990
[TBL] [Abstract][Full Text] [Related]
35. Microglial proliferation and monocyte infiltration contribute to microgliosis following status epilepticus.
Feng L; Murugan M; Bosco DB; Liu Y; Peng J; Worrell GA; Wang HL; Ta LE; Richardson JR; Shen Y; Wu LJ
Glia; 2019 Aug; 67(8):1434-1448. PubMed ID: 31179602
[TBL] [Abstract][Full Text] [Related]
36. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
37. Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?
Lauro C; Catalano M; Trettel F; Limatola C
Ann N Y Acad Sci; 2015 Sep; 1351():141-8. PubMed ID: 26084002
[TBL] [Abstract][Full Text] [Related]
38. CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.
Wu XM; Liu Y; Qian ZM; Luo QQ; Ke Y
Mol Neurobiol; 2016 Aug; 53(6):4010-4018. PubMed ID: 26189830
[TBL] [Abstract][Full Text] [Related]
39. Compromised fractalkine signaling delays microglial occupancy of emerging modules in the multisensory midbrain.
Brett CA; Carroll JB; Gabriele ML
Glia; 2022 Apr; 70(4):697-711. PubMed ID: 35132709
[TBL] [Abstract][Full Text] [Related]
40. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression.
Noda M; Doi Y; Liang J; Kawanokuchi J; Sonobe Y; Takeuchi H; Mizuno T; Suzumura A
J Biol Chem; 2011 Jan; 286(3):2308-19. PubMed ID: 21071446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]